Literature DB >> 17921823

Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension.

Robert H Fagard1, Katarzyna Stolarz, Tatiana Kuznetsova, Jitka Seidlerova, Valérie Tikhonoff, Tomasz Grodzicki, Yuri Nikitin, Jan Filipovsky, Jan Peleska, Edoardo Casiglia, Lutgarde Thijs, Jan A Staessen, Kalina Kawecka-Jaszcz.   

Abstract

OBJECTIVE: To assess, in a population-based approach, sympathetic nervous system activity by the use of power spectral analysis of heart rate variability, in normotension, white-coat hypertension, masked hypertension and sustained hypertension.
METHODS: The electrocardiographic RR interval was registered in the supine and standing positions and the low-frequency and high-frequency components of its variability were quantified. Cut-off values of 140/90 mmHg for conventional blood pressure and 135/85 mmHg for daytime ambulatory blood pressure were used to define the four blood pressure groups.
RESULTS: After exclusion of patients with diabetes, myocardial infarction or treated hypertension, 1485 subjects with complete data remained for the analysis in the supine position. Age averaged 39 +/- 14 years; 54% were women. Conventional and ambulatory blood pressure averaged, respectively, 122 +/- 16/79 +/- 11 mmHg and 124 +/- 12/77 +/- 8 mmHg. After adjusting for demographic, anthropometric and lifestyle characteristics, the low-frequency to high-frequency ratio (geometric mean) averaged 0.81 in normotension and was significantly higher in white-coat hypertension (1.11; P < 0.001), based on a higher low-frequency component and a lower high-frequency component (P < 0.01). This ratio was not significantly different between normotension, masked hypertension (0.97) and sustained hypertension (0.93). The adjusted standing-to-supine ratio of the high-frequency component (geometric mean) was significantly higher in sustained hypertension (0.50) than in normotension (0.39; P < 0.01), but not in white-coat (0.40) and masked hypertension (0.45).
CONCLUSION: The findings at rest are compatible with increased sympathetic activity and decreased parasympathetic modulation in white-coat hypertension, with normal autonomic cardiac regulation in masked and sustained hypertension. In addition, sustained hypertension is characterized by a blunted decrease of the high-frequency component on standing.

Entities:  

Mesh:

Year:  2007        PMID: 17921823     DOI: 10.1097/HJH.0b013e3282efc1fe

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  13 in total

Review 1.  The role of cardiac autonomic function in hypertension and cardiovascular disease.

Authors:  Paolo Palatini; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

2.  Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension.

Authors:  Abdullah Shehab; Abdishakur Abdulle
Journal:  BMC Cardiovasc Disord       Date:  2011-01-11       Impact factor: 2.298

Review 3.  Autonomic nervous system dysregulation in pediatric hypertension.

Authors:  Janusz Feber; Marcel Ruzicka; Pavel Geier; Mieczyslaw Litwin
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

4.  Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study.

Authors:  Keith M Diaz; Praveen Veerabhadrappa; Michael D Brown; Matthew C Whited; Patricia M Dubbert; DeMarc A Hickson
Journal:  Am J Hypertens       Date:  2014-12-12       Impact factor: 2.689

5.  Comparison of the differences in circadian autonomic function in hyperlipidemic men with and without erectile dysfunction.

Authors:  M Tolga Dogru; M Murad Basar
Journal:  Int Urol Nephrol       Date:  2009-10-29       Impact factor: 2.370

6.  Association of thyroid function with white coat hypertension and sustained hypertension.

Authors:  Peng Cai; Yan Peng; YuXi Chen; Li Li; Wei Chu; Yan Wang; Xukai Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-11       Impact factor: 3.738

7.  Sex differences in primary hypertension.

Authors:  Kathryn Sandberg; Hong Ji
Journal:  Biol Sex Differ       Date:  2012-03-14       Impact factor: 5.027

Review 8.  White-coat hypertension should not be treated in subjects with diabetes.

Authors:  Michael Bursztyn; Iddo Z Ben-Dov
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

9.  Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study.

Authors:  Heba Alwan; Menno Pruijm; Belen Ponte; Daniel Ackermann; Idris Guessous; Georg Ehret; Jan A Staessen; Kei Asayama; Philippe Vuistiner; Sandrine Estoppey Younes; Fred Paccaud; Grégoire Wuerzner; Antoinette Pechere-Bertschi; Markus Mohaupt; Bruno Vogt; Pierre-Yves Martin; Michel Burnier; Murielle Bochud
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Nonlinear Conte-Zbilut-Federici (CZF) Method of Computing LF/HF Ratio: A More Reliable Index of Changes in Heart Rate Variability.

Authors:  Vernon Bond; Bryan H Curry; Krishna Kumar; Sudhakar Pemminati; Vasavi R Gorantla; Kishan Kadur; Richard M Millis
Journal:  J Pharmacopuncture       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.